SG Americas Securities LLC Sells 308,835 Shares of Surgery Partners, Inc. $SGRY

SG Americas Securities LLC cut its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 54.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 258,141 shares of the company’s stock after selling 308,835 shares during the quarter. SG Americas Securities LLC owned approximately 0.20% of Surgery Partners worth $3,077,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Hsbc Holdings PLC boosted its stake in Surgery Partners by 104.2% in the fourth quarter. Hsbc Holdings PLC now owns 1,931,577 shares of the company’s stock worth $30,151,000 after buying an additional 985,748 shares in the last quarter. Alpine Global Management LLC purchased a new stake in shares of Surgery Partners in the 4th quarter valued at $175,000. Empowered Funds LLC grew its holdings in shares of Surgery Partners by 1,340.9% during the 4th quarter. Empowered Funds LLC now owns 161,419 shares of the company’s stock valued at $2,494,000 after purchasing an additional 150,216 shares during the last quarter. One68 Global Capital LLC bought a new position in shares of Surgery Partners during the 4th quarter valued at $371,000. Finally, Man Group plc purchased a new position in Surgery Partners in the 4th quarter worth $5,080,000.

Surgery Partners Price Performance

SGRY stock opened at $16.80 on Wednesday. The stock has a market capitalization of $2.20 billion, a price-to-earnings ratio of -28.00, a PEG ratio of 4.95 and a beta of 1.96. The firm’s 50-day moving average price is $14.31 and its two-hundred day moving average price is $14.36. The company has a current ratio of 1.86, a quick ratio of 1.69 and a debt-to-equity ratio of 1.17. Surgery Partners, Inc. has a 12-month low of $11.41 and a 12-month high of $24.10.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings results on Tuesday, May 5th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.12. Surgery Partners had a positive return on equity of 1.04% and a negative net margin of 2.28%.The company had revenue of $810.90 million for the quarter, compared to the consensus estimate of $797.69 million. During the same quarter in the previous year, the business earned $0.04 EPS. Surgery Partners’s revenue was up 4.5% compared to the same quarter last year. As a group, equities analysts predict that Surgery Partners, Inc. will post 0.25 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on SGRY. Barclays cut their price target on shares of Surgery Partners from $18.00 to $14.00 and set an “equal weight” rating for the company in a research report on Tuesday, March 3rd. Mizuho decreased their price objective on Surgery Partners from $19.00 to $17.00 and set an “outperform” rating on the stock in a report on Thursday, March 5th. Weiss Ratings reissued a “sell (e+)” rating on shares of Surgery Partners in a research note on Tuesday, May 26th. Cantor Fitzgerald restated an “overweight” rating on shares of Surgery Partners in a report on Wednesday, March 4th. Finally, Benchmark restated a “buy” rating on shares of Surgery Partners in a research report on Tuesday, March 3rd. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Surgery Partners currently has a consensus rating of “Moderate Buy” and an average target price of $22.18.

Surgery Partners Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.